WO2024050998A1 - Nucleic acid detection reagent for rapidly detecting pathogen of pets, and kit and use thereof - Google Patents
Nucleic acid detection reagent for rapidly detecting pathogen of pets, and kit and use thereof Download PDFInfo
- Publication number
- WO2024050998A1 WO2024050998A1 PCT/CN2022/135025 CN2022135025W WO2024050998A1 WO 2024050998 A1 WO2024050998 A1 WO 2024050998A1 CN 2022135025 W CN2022135025 W CN 2022135025W WO 2024050998 A1 WO2024050998 A1 WO 2024050998A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass concentration
- solution
- nucleic acid
- protein
- tris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention belongs to the field of biosafety technology. Specifically, it particularly relates to a reagent, a kit and an application thereof that can quickly detect pet infection virus nucleic acid at room temperature.
- nucleic acid detection For a long time, the shortcomings of extracting nucleic acids (DNA and RNA) from biologically active samples and their purification steps are numerous and time-consuming, which have hindered the rapid development of nucleic acid detection. Especially when the titer of the pathogen in the test sample is low, whether the nucleic acid in the sample can be completely extracted and stored affects the subsequent test results. Therefore, solving the two problems of multiple nucleic acid extraction steps and long time is of great significance for nucleic acid detection.
- the method of adding nuclease inhibitors and heating in a water bath is generally used to lyse microorganisms or cells and release nucleic acids.
- the Hudson method involves adding EDTA and TCEP, first bathing in water at 60°C for 2 minutes to inactivate microorganisms, and then raising the temperature to 95°C for 10 minutes to obtain an extraction solution mixed with nucleic acids. Due to its simple operation, the next step of detection can be carried out directly without purification. It is low cost, easy to operate, and has low nucleic acid loss. It can be used as one of the rapid detection operations.
- Nucleic acid extraction solutions available on the market usually add guanidinium isothiocyanate as a lysis component. Although it can destroy virus activity at room temperature and release nucleic acids, it usually requires more than ten minutes of lysis time to achieve the best results. Extraction effect.
- nucleic acid extraction method is alkaline lysis.
- Chinese patent application CN201210242862.6 uses a strong alkaline solution to lyse cells in biological samples at high temperatures to release nucleic acids, and then adds acidic buffer for neutralization and centrifugation to obtain the extracted nucleic acid solution. Its high temperature and centrifugation steps also make rapid extraction difficult.
- Nucleic acid extraction is a key step in nucleic acid amplification technology.
- the methods for extracting nucleic acids in laboratories are usually cumbersome, a simple, fast, efficient, and low-energy-consuming nucleic acid extraction method is needed.
- Commonly used methods for rapid nucleic acid extraction include solid-phase extraction kit rapid extraction method, magnetic bead method, alumina membrane method and lysis solution treatment method.
- the solid-phase extraction method requires the operation of instruments such as centrifuges, the magnetic bead method has high processing costs, and the aluminum oxide membrane method has a complicated manufacturing process, which limits its more practical and effective application in rapid nucleic acid detection.
- the constant temperature rapid extraction method of lysate is simple to operate, cheap and easy to obtain, and is an ideal nucleic acid extraction method.
- the present invention provides a reagent, a kit and its application that can quickly detect pet infection virus nucleic acid at room temperature.
- the reagent, kit and its application all use highly alkaline nucleic acid extraction solutions.
- the nucleic acid in the sample is extracted, and then the acidic stop solution is added to the extraction solution to neutralize it for the next step of amplification.
- the alkali concentration of the alkaline nucleic acid extraction solution is appropriately reduced, and EDTA is added to the extraction solution to inhibit nuclease activity; Tris is also added as a buffer system. After adding the acidic stop solution, there is a buffer system in the liquid, and errors caused by operation Little effect on pH.
- nucleic acids can also be extracted when using lysis buffer, but the lysis effect will be affected by the state of the sample. To obtain the best extraction results, the sample can be properly pretreated.
- the present invention adopts the following technical solutions.
- a reagent for rapid nucleic acid detection of pet pathogens includes an extraction solution, a stop solution, a TSA reaction solution, a Cas12a detection solution, and a colloidal gold test strip;
- the extraction liquid includes strong alkali hydroxide and Tris-HCl;
- the stop solution includes acetic acid and Tris acetic acid
- the TSA reaction solution includes UvsX protein, UvsY protein, GP32 protein, Bsu protein, dNTP, ATP, Tris buffer, creatine phosphate, creatine kinase, polyethylene glycol 35000 and MgOAc;
- the Cas12a detection solution includes Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA;
- the colloidal gold test strip includes a T band and a C band, where the T band is labeled with streptavidin and the C band is labeled with anti-anti-FAM antibody.
- the mass concentration of the strong alkali hydroxide is 25mM ⁇ 500mM, and the strong alkali hydroxide is NaOH,
- the mass concentration of Tris-HCl is 10mM ⁇ 70mM
- the mass concentration of EDTA is 10mM ⁇ 50mM;
- the pH value of the extraction liquid is 11.4-13.7.
- the mass concentration of the acetic acid is 1M ⁇ 5M
- the mass concentration of Tris-acetic acid is 1M
- the pH value of the stop solution is 2-2.5.
- the mass concentration of the UvsX protein is 100-300ng/ ⁇ L
- the mass concentration of the UvsY protein is 50-100ng/ ⁇ L
- the mass concentration of the GP32 protein is 100-500ng/ ⁇ L
- the mass concentration of the Bsu protein is 50-200ng/ ⁇ L
- the mass concentration of the dNTP is 150-300 ⁇ M
- the mass concentration of ATP is 2-10mM
- the mass concentration of the Tris buffer is 20-80mM
- the mass concentration of creatine phosphate is 20-80mM
- the mass concentration of creatine kinase is 30-100ng/ ⁇ L
- the mass concentration of polyethylene glycol 35000 is 1-7% (w/v),
- the mass concentration of MgOAc is 20mM.
- the mass concentration of the Cas12a protein is 1-10uM
- the mass concentration of NaCl is 20-75mM
- the mass concentration of Tris-HCl is 5-15mM
- the mass concentration of MgCl 2 is 1-20mM
- the mass concentration of the BSA is 50-150ug/ml
- the mass concentration of crRNA is 10-50nM
- the mass concentration of the FAM-Bio modified ssDNA is 1-100nM
- the pH value of the Cas12a detection solution is 7.9.
- a kit as described above is used in detecting nucleic acid of pet pathogens.
- step (2) Add all the stop solution to the sample nucleic acid solution obtained in step (1) to neutralize the pH of the sample nucleic acid solution and obtain a mixed solution; the mixed pH value is 6.5-8;
- the pH of the mixed solution is 6.5-8.
- the extracted nucleic acid can be stored for a long time and can be used for various detection and amplification;
- the nucleic acid amplification method provided by the present invention has a wide amplification temperature range and can complete the amplification operation in a short time without the need for large-scale precision equipment or professionals;
- Figure 1 is a diagram of the extraction effect (PCR verification) of the extraction solution under different extraction times of the present invention
- Figure 2 shows the effect of nucleic acid amplification at different temperatures
- Figure 3 shows the effect of nucleic acid amplification at different times
- Figure 4 is a schematic diagram of the principle of isothermal nucleic acid amplification
- Figure 5 shows the cleavage effect of Cas12a at different concentrations
- Figure 6 shows the test results of colloidal gold test strips.
- a reagent for rapid nucleic acid detection of pet pathogens includes an extraction solution, a stop solution, a TSA reaction solution, a Cas12a detection solution, and a colloidal gold test strip;
- the extraction liquid includes strong alkali hydroxide and Tris-HCl;
- the stop solution includes acetic acid and Tris acetic acid
- the TSA reaction solution includes UvsX protein, UvsY protein, GP32 protein, Bsu protein, dNTP, ATP, Tris buffer, creatine phosphate, creatine kinase, polyethylene glycol 35000 and MgOAc;
- the Cas12a detection solution includes Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA;
- the colloidal gold test strip includes a T band and a C band, where the T band is labeled with streptavidin and the C band is labeled with anti-anti-FAM antibody.
- the mass concentration of the strong alkali hydroxide is 25mM ⁇ 500mM, and the strong alkali hydroxide is NaOH,
- the mass concentration of Tris-HCl is 10mM ⁇ 70mM
- the mass concentration of EDTA is 10mM ⁇ 50mM;
- the pH value of the extraction liquid is 11.4-13.7.
- the mass concentration of the acetic acid is 1M ⁇ 5M
- the mass concentration of Tris-acetic acid is 1M
- the pH value of the stop solution is 2-2.5.
- the mass concentration of the UvsX protein is 100-300ng/ ⁇ L
- the mass concentration of the UvsY protein is 50-100ng/ ⁇ L
- the mass concentration of the GP32 protein is 100-500ng/ ⁇ L
- the mass concentration of the Bsu protein is 50-200ng/ ⁇ L
- the mass concentration of the dNTP is 150-300 ⁇ M
- the mass concentration of ATP is 2-10mM
- the mass concentration of the Tris buffer is 20-80mM
- the mass concentration of creatine phosphate is 20-80mM
- the mass concentration of creatine kinase is 30-100ng/ ⁇ L
- the mass concentration of polyethylene glycol 35000 is 1-7% (w/v),
- the mass concentration of MgOAc is 20mM.
- the mass concentration of the Cas12a protein is 1-10uM
- the mass concentration of NaCl is 20-75mM
- the mass concentration of Tris-HCl is 5-15mM
- the mass concentration of MgCl 2 is 1-20mM
- the mass concentration of the BSA is 50-150ug/ml
- the mass concentration of crRNA is 10-50nM
- the mass concentration of the FAM-Bio modified ssDNA is 1-100nM
- the pH value of the Cas12a detection solution is 7.9.
- a kit as described above is used in detecting nucleic acid of pet pathogens.
- step (2) Add all the stop solution to the sample nucleic acid solution obtained in step (1) to neutralize the pH of the sample nucleic acid solution and obtain a mixed solution; the mixed pH value is 6.5-8;
- the pH of the mixed solution is 6.5-8.
- the present invention adopts the following nucleic acid extraction technical solution: a strong alkaline nucleic acid extraction method, including the following steps: putting the sample into an extraction solution (a strong alkali hydroxide solution with a concentration of 25mM to 500mM) to extract nucleic acids; Shake and mix well, let stand at room temperature for extraction for 2 minutes; add stop solution (HCl solution with a concentration of 0.1M-1.5M and a pH of 0.1-1) and shake to mix.
- an extraction solution a strong alkali hydroxide solution with a concentration of 25mM to 500mM
- stop solution HCl solution with a concentration of 0.1M-1.5M and a pH of 0.1-1
- the strong alkali hydroxide is NaOH or KOH
- the volume of the extraction liquid is 200 ⁇ l
- the volume of the stop solution is 200 ⁇ l
- the nucleic acid can be stored at -20°C for one month;
- the present invention can meet the existing needs of various molecular biology detection and amplification by changing the concentration, pH value, extraction temperature and time of reagents and other parameters, and can use the same equipment at the same time. Automatic DNA and RNA extraction work is performed simultaneously under experimental conditions.
- the present invention adopts the following nucleic acid amplification system solution: including UvsX protein, UvsY protein, GP32 protein and Bsu protein:
- the UvsX protein is any one of the following:
- the UvsY protein is any one of the following:
- the single-chain binding protein GP32 is any of the following:
- DNA polymerase Bsu is any one of the following:
- the mass ratio of the UvsX protein, UvsY protein, single-chain binding protein GP32, and Bsu protein is 1: (0.1-4.5): (0.75-2.4): (0.17-0.82); it is recommended that the UvsX be preferred
- the mass ratio of protein, UvsY protein, single-chain binding protein GP32, and Bsu protein is 260:88:300:90.
- it also includes one or more of magnesium ion reaction initiator, dNTP, ATP, Tris-HCl buffer, creatine phosphate, creatine kinase (CK), and polyethylene glycol (PEG35000).
- magnesium ion reaction initiator dNTP
- ATP Tris-HCl buffer
- CK creatine kinase
- PEG35000 polyethylene glycol
- the reaction starter is magnesium ion, and the concentration of the starter in the reaction system is 20mM.
- reaction initiator magnesium ion is MgCl 2 or MgOAc.
- the reaction system contains the following materials: a pair of forward and reverse primers (concentration of each primer is 300-600nM), 100-300ng/ ⁇ L UvsX protein, 50-100ng/ ⁇ L UvsY protein, 100-500ng/ ⁇ L GP32 protein, 50 -200ng/ ⁇ L Bsu protein, 150-300 ⁇ M dNTP, 2-10mM ATP, 20-80mM Tris buffer, 20-80mM creatine phosphate; 3 0-100ng/ ⁇ L creatine kinase; 1-7% (w/v) Polyethylene glycol 35000, 20mM MgOAc.
- a kit for isothermal nucleic acid detection which includes the above system.
- An isothermal nucleic acid detection method the sample to be tested is added to the above screening system, and the reaction is carried out at a constant temperature for 15-30 minutes; at 30°C-47°C, the reaction is carried out at a constant temperature for 15-30 minutes; the method is a non-disease diagnosis and treatment method.
- the sample to be tested is DNA or RNA.
- RNA reverse transcriptase (MuLV) needs to be added to the reaction system.
- the present invention adopts the following nucleic acid detection method: including Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA.
- the NaCl concentration is 5mM
- the Tris-HCl concentration is 1mM
- the MgCl2 concentration is 1mM
- the BSA concentration is 10 ⁇ g/ml
- the Cas12a concentration is 10 ⁇ M
- the crRNA concentration is 50nM
- the ssDNA reporter concentration is 15nM.
- MgCl2 can be replaced with MgOAc.
- the ssDNA reporter concentration can be replaced with 10mM.
- the ssDNA reporter concentration can be replaced with 5mM.
- the steps for extracting feline parvovirus are as follows:
- reaction system 50 ⁇ L system: 5 ⁇ L template DNA e, primer I (420nM each primer), 1 ⁇ l MuLV reverse transcriptase, 260ng/ ⁇ L UvsX protein, 88ng/ ⁇ L UvsY protein, 300ng/ ⁇ L GP32 protein, 90ng/ ⁇ L Bsu protein, 240 ⁇ M dNTP, 5mM ATP, 100mM potassium acetate, 100mM Tris buffer, 40mM creatine phosphate; 90ng/ ⁇ L creatine kinase; 6% polyethylene glycol 35000.
- reaction system 50 ⁇ L system: 5 ⁇ L template DNA e, primer I (420nM each primer), 1 ⁇ l MuLV reverse transcriptase, 260ng/ ⁇ L UvsX protein, 88ng/ ⁇ L UvsY protein, 300ng/ ⁇ L GP32 protein, 90ng/ ⁇ L Bsu protein, 240 ⁇ M dNTP, 5mM ATP, 100mM potassium acetate, 100mM Tris buffer, 40mM creatine phosphate; 90ng/ ⁇ L creatine kinase; 6% polyethylene glycol 35000.
- reaction system (20 ⁇ l system): NaCl 5mM, Tris-HCl 1mM, MgCl 2 1mM, BSA 10 ⁇ g/ml, crRNA 50nM, ssDNA reporter 15nM (FQ modification), Target (u) 2 ⁇ l.
- Cas12a is not added to v-;
- Cas12a was added to w- at a final concentration of 1 ⁇ M
- reaction system (20 ⁇ l system): NaCl 5mM, Tris-HCl 1mM, MgCl 2 1mM, BSA 10 ⁇ g/ml, crRNA 50nM, ssDNA reporter 15nM (F-Bio modified).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
本发明属于生物安全技术领域,具体地说,特别涉及一种可以快速常温对宠物感染病毒核酸检测的试剂、试剂盒及其应用。The invention belongs to the field of biosafety technology. Specifically, it particularly relates to a reagent, a kit and an application thereof that can quickly detect pet infection virus nucleic acid at room temperature.
随着分子生物学技术得快速发展,它不仅仅涉及生物学、医学、遗传学、植物学、动物学等方面,更逐渐成为实际应用的底层技术。PCR作为一个已经较为成熟的技术,其具有高特异性、高效率等特点,但是一直难以摆脱需要洁净等级较高的实验室和专业的操作人员的束缚。With the rapid development of molecular biology technology, it not only involves biology, medicine, genetics, botany, zoology, etc., but also gradually becomes the underlying technology for practical applications. As a relatively mature technology, PCR has the characteristics of high specificity and high efficiency. However, it has been difficult to get rid of the constraints of laboratories with higher cleanliness levels and professional operators.
长期以来,生物活性样本中提取核酸(DNA和RNA)以及其纯化步骤繁多、耗时较多等缺点,使得核酸检测变成快速检测存在阻碍。尤其当检测样本中病原体滴度较低时,是否能将样本中的核酸完整提取并保存影响后续的检测结果。因此解决核酸提取步骤多、时间长这两个问题对于核酸检测具有重要意义。For a long time, the shortcomings of extracting nucleic acids (DNA and RNA) from biologically active samples and their purification steps are numerous and time-consuming, which have hindered the rapid development of nucleic acid detection. Especially when the titer of the pathogen in the test sample is low, whether the nucleic acid in the sample can be completely extracted and stored affects the subsequent test results. Therefore, solving the two problems of multiple nucleic acid extraction steps and long time is of great significance for nucleic acid detection.
对于粗糙样本(拭子、血液等)一般采用添加核酸酶抑制剂后水浴加热的方法,使得微生物或者细胞裂解,释放核酸。Hudson法即为加入EDTA和TCEP后,首先水浴60℃2分钟,将微生物灭活,随后升温到95℃10分钟,即得到混有核酸的提取液。由于其操作简单,无需提纯可以直接进行下一步检测,成本低廉,易操作,核酸损失量少等特点,可以作为快速检测的操作之一For rough samples (swabs, blood, etc.), the method of adding nuclease inhibitors and heating in a water bath is generally used to lyse microorganisms or cells and release nucleic acids. The Hudson method involves adding EDTA and TCEP, first bathing in water at 60°C for 2 minutes to inactivate microorganisms, and then raising the temperature to 95°C for 10 minutes to obtain an extraction solution mixed with nucleic acids. Due to its simple operation, the next step of detection can be carried out directly without purification. It is low cost, easy to operate, and has low nucleic acid loss. It can be used as one of the rapid detection operations.
市面上可以购买到的核酸提取液(保存液)通常加入了异硫氰酸胍作为裂解成分,虽然可以常温破坏病毒活性并且使核酸释放,但是通常需要十分钟以上的裂解时间以达到最好的提取效果。Nucleic acid extraction solutions (preservation solutions) available on the market usually add guanidinium isothiocyanate as a lysis component. Although it can destroy virus activity at room temperature and release nucleic acids, it usually requires more than ten minutes of lysis time to achieve the best results. Extraction effect.
此外还有一种常用的核酸提取方法就是碱裂解法。如中国专利申请CN201210242862.6,其利用强碱溶液在高温下让生物样本中的细胞发生裂解,释放出核酸,然后加入酸性缓冲液进行中和,进行离心,获得所提取的核酸溶液。其高温和离心步骤同时也给快速提取带来了困难。In addition, another commonly used nucleic acid extraction method is alkaline lysis. For example, Chinese patent application CN201210242862.6 uses a strong alkaline solution to lyse cells in biological samples at high temperatures to release nucleic acids, and then adds acidic buffer for neutralization and centrifugation to obtain the extracted nucleic acid solution. Its high temperature and centrifugation steps also make rapid extraction difficult.
不论采用Hudson法还是碱裂解法,利用现有技术提取和检测样本中的核酸都会涉及到加热步骤,而且加热过程的等待时间、使用电器和加热设备带来的危险性都与快速检测的初衷相反。Regardless of whether the Hudson method or the alkaline lysis method is used, the extraction and detection of nucleic acids in samples using existing technologies will involve a heating step, and the waiting time of the heating process and the dangers caused by the use of electrical appliances and heating equipment are contrary to the original intention of rapid detection. .
近年来,恒温扩增技术与CRISPR基因编辑技术结合为核酸恒温扩增检测技术的发展创建了一个新的平台。目前等温扩增和基因编辑检测病原体的步骤包括核酸提取、恒温扩增、 Cas蛋白编辑以及产物检测。In recent years, the combination of isothermal amplification technology and CRISPR gene editing technology has created a new platform for the development of nucleic acid isothermal amplification detection technology. The current steps for isothermal amplification and gene editing to detect pathogens include nucleic acid extraction, isothermal amplification, Cas protein editing, and product detection.
核酸提取是核酸扩增技术中的关键步骤,但因实验室提取核酸的方法通常比较繁琐,需要一种简便、快速、高效、低耗能的核酸提取方法。常用的快速提取核酸的方法有固相提取试剂盒快速提取法,磁珠法,氧化铝膜法和裂解液处理法等。但固相提取法需要依靠仪器操作如离心机,磁珠法处理成本高,氧化铝膜法制造工艺复杂,限制了其在核酸快速检测中得到更实际有效的应用。裂解液恒温快速提取法操作简单、价格便宜、获取方便,是十分理想的核酸提取方法。Nucleic acid extraction is a key step in nucleic acid amplification technology. However, because the methods for extracting nucleic acids in laboratories are usually cumbersome, a simple, fast, efficient, and low-energy-consuming nucleic acid extraction method is needed. Commonly used methods for rapid nucleic acid extraction include solid-phase extraction kit rapid extraction method, magnetic bead method, alumina membrane method and lysis solution treatment method. However, the solid-phase extraction method requires the operation of instruments such as centrifuges, the magnetic bead method has high processing costs, and the aluminum oxide membrane method has a complicated manufacturing process, which limits its more practical and effective application in rapid nucleic acid detection. The constant temperature rapid extraction method of lysate is simple to operate, cheap and easy to obtain, and is an ideal nucleic acid extraction method.
发明内容Contents of the invention
1、要解决的问题1. Problems to be solved
针对现有技术的不足之处,本发明提供一种可以快速常温对宠物感染病毒核酸检测的试剂、试剂盒及其应用,所述试剂、试剂盒及其应用均使用强碱性的核酸提取液提取样本中的核酸,然后酸性终止液加入提取液中进行中和,以进行下一步扩增。其中碱性核酸提取液的碱浓度适当降低,并在提取液中加入EDTA,抑制核酸酶活性;同时加入Tris作为缓冲体系,在加入酸性终止液之后,液体内存在缓冲体系,因操作引起的误差对pH影响小。对于血清、血浆、全血、尿液、口鼻眼分泌物、生殖道分泌物、肛拭子、粪便等复杂样本,使用裂解液时同样可以提取出核酸,但裂解效果会受样本状态影响,为获得最好的提取效果,可以对样本进行适当的前处理。In view of the shortcomings of the existing technology, the present invention provides a reagent, a kit and its application that can quickly detect pet infection virus nucleic acid at room temperature. The reagent, kit and its application all use highly alkaline nucleic acid extraction solutions. The nucleic acid in the sample is extracted, and then the acidic stop solution is added to the extraction solution to neutralize it for the next step of amplification. The alkali concentration of the alkaline nucleic acid extraction solution is appropriately reduced, and EDTA is added to the extraction solution to inhibit nuclease activity; Tris is also added as a buffer system. After adding the acidic stop solution, there is a buffer system in the liquid, and errors caused by operation Little effect on pH. For complex samples such as serum, plasma, whole blood, urine, mouth, nose and eye secretions, reproductive tract secretions, anal swabs, feces and other complex samples, nucleic acids can also be extracted when using lysis buffer, but the lysis effect will be affected by the state of the sample. To obtain the best extraction results, the sample can be properly pretreated.
2、技术方案2. Technical solutions
为解决上述问题,本发明采用如下的技术方案。In order to solve the above problems, the present invention adopts the following technical solutions.
一种快速检测宠物病原体核酸检测的试剂,所述的试剂包括提取液、终止液、TSA反应液、Cas12a检测液、胶体金试纸条;A reagent for rapid nucleic acid detection of pet pathogens. The reagent includes an extraction solution, a stop solution, a TSA reaction solution, a Cas12a detection solution, and a colloidal gold test strip;
所述的提取液包括强碱氢氧化物、Tris-HCl;The extraction liquid includes strong alkali hydroxide and Tris-HCl;
所述的终止液包括醋酸、Tris醋酸;The stop solution includes acetic acid and Tris acetic acid;
所述的TSA反应液包括UvsX蛋白、UvsY蛋白、GP32蛋白、Bsu蛋白、dNTP、ATP、Tris缓冲液、磷酸肌酸、肌酸激酶、聚乙二醇35000及MgOAc;The TSA reaction solution includes UvsX protein, UvsY protein, GP32 protein, Bsu protein, dNTP, ATP, Tris buffer, creatine phosphate, creatine kinase, polyethylene glycol 35000 and MgOAc;
所述的Cas12a检测液包括Cas12a蛋白、NaCl、Tris-HCl、MgCl 2、BSA、crRNA及FAM-Bio修饰的ssDNA; The Cas12a detection solution includes Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA;
所述的胶体金试纸条包括T带与C带,其中T带标记有链霉亲和素,C带标记有抗-抗FAM抗体。The colloidal gold test strip includes a T band and a C band, where the T band is labeled with streptavidin and the C band is labeled with anti-anti-FAM antibody.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的提取液中:In the extract:
所述的强碱氢氧化物的质量浓度为25mM~500mM,所述的强碱氢氧化物为NaOH,The mass concentration of the strong alkali hydroxide is 25mM ~ 500mM, and the strong alkali hydroxide is NaOH,
所述的Tris-HCl的质量浓度为10mM~70mM,The mass concentration of Tris-HCl is 10mM ~ 70mM,
所述的EDTA的质量浓度为10mM~50mM;The mass concentration of EDTA is 10mM ~ 50mM;
所述的提取液的pH值为11.4~13.7。The pH value of the extraction liquid is 11.4-13.7.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的终止液中:In the stop solution:
所述的醋酸的质量浓度为1M~5M,The mass concentration of the acetic acid is 1M ~ 5M,
所述的Tris-醋酸的质量浓度为1M;The mass concentration of Tris-acetic acid is 1M;
所述的终止液的pH值为2~2.5。The pH value of the stop solution is 2-2.5.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的TSA反应液中:In the TSA reaction solution:
所述的UvsX蛋白的质量浓度为100-300ng/μL,The mass concentration of the UvsX protein is 100-300ng/μL,
所述的UvsY蛋白的质量浓度为50-100ng/μL,The mass concentration of the UvsY protein is 50-100ng/μL,
所述的GP32蛋白的质量浓度为100-500ng/μL,The mass concentration of the GP32 protein is 100-500ng/μL,
所述的Bsu蛋白的质量浓度为50-200ng/μL,The mass concentration of the Bsu protein is 50-200ng/μL,
所述的dNTP的质量浓度为150-300μM,The mass concentration of the dNTP is 150-300 μM,
所述的ATP的质量浓度为2-10mM,The mass concentration of ATP is 2-10mM,
所述的Tris缓冲液的质量浓度为20-80mM,The mass concentration of the Tris buffer is 20-80mM,
所述的磷酸肌酸的质量浓度为20-80mM,The mass concentration of creatine phosphate is 20-80mM,
所述的肌酸激酶的质量浓度为30-100ng/μL,The mass concentration of creatine kinase is 30-100ng/μL,
所述的聚乙二醇35000的质量浓度为1-7%(w/v),The mass concentration of polyethylene glycol 35000 is 1-7% (w/v),
所述的MgOAc的质量浓度为20mM。The mass concentration of MgOAc is 20mM.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的Cas12a检测液中:In the Cas12a detection solution:
所述的Cas12a蛋白的质量浓度为1-10uM,The mass concentration of the Cas12a protein is 1-10uM,
所述的NaCl的质量浓度为20-75mM,The mass concentration of NaCl is 20-75mM,
所述的Tris-HCl的质量浓度为5-15mM,The mass concentration of Tris-HCl is 5-15mM,
所述的MgCl 2的质量浓度为1-20mM, The mass concentration of MgCl 2 is 1-20mM,
所述的BSA的质量浓度为50-150ug/ml,The mass concentration of the BSA is 50-150ug/ml,
所述的crRNA的质量浓度为10-50nM,The mass concentration of crRNA is 10-50nM,
所述的FAM-Bio修饰的ssDNA的质量浓度为1-100nM,The mass concentration of the FAM-Bio modified ssDNA is 1-100nM,
所述的Cas12a检测液的pH值为7.9。The pH value of the Cas12a detection solution is 7.9.
一种含有上述所述的试剂的试剂盒。A kit containing the above-mentioned reagents.
一种如上述所述的试剂盒在检测宠物病原体核酸中应用。A kit as described above is used in detecting nucleic acid of pet pathogens.
上述所述的应用,The applications mentioned above,
包括以下步骤:Includes the following steps:
(1)利用所述的提取液提取样本中的核酸,获得样本核酸溶液;(1) Extract the nucleic acid in the sample using the extraction solution to obtain a sample nucleic acid solution;
(2)将所述的终止液全部加入步骤(1)中所获得的样本核酸溶液,以中和样本核酸溶液的pH并得到混合液;其中混合的pH值为6.5-8;(2) Add all the stop solution to the sample nucleic acid solution obtained in step (1) to neutralize the pH of the sample nucleic acid solution and obtain a mixed solution; the mixed pH value is 6.5-8;
(3)利用所述的混合液进行扩增反应并检测样本中的核酸。(3) Use the mixed solution to perform an amplification reaction and detect nucleic acids in the sample.
所述混合液的pH为6.5~8。The pH of the mixed solution is 6.5-8.
相比于现有技术,本发明的有益效果为:Compared with the existing technology, the beneficial effects of the present invention are:
(1)相比于繁琐、条件复杂的核酸提取,只需要2分钟和2步加样即可提取出样本核酸;(1) Compared with the cumbersome and complicated nucleic acid extraction, it only takes 2 minutes and 2 steps to extract the sample nucleic acid;
(2)提取的核酸可以较长时间保存,且可用于各种检测、扩增;(2) The extracted nucleic acid can be stored for a long time and can be used for various detection and amplification;
(3)本发明提供的核酸扩增方法,且可扩增温度范围较大,可以无需大型精密仪器设备或专业人员即可短时间内完成扩增操作;(3) The nucleic acid amplification method provided by the present invention has a wide amplification temperature range and can complete the amplification operation in a short time without the need for large-scale precision equipment or professionals;
(4)第一步核酸提取和第二步核酸扩增结合可以在采样现场快速完成布置和检测。(4) The combination of the first step of nucleic acid extraction and the second step of nucleic acid amplification can quickly complete the arrangement and detection at the sampling site.
为了更清楚地说明本发明具体实施方式或现有技术中地技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单的介绍。显而易见的,下面描述中的附图是本发明的一些实施方式,对于本领域普通技术人员而言,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly explain the specific embodiments of the present invention or the technical solutions in the prior art, the following will briefly introduce the drawings that need to be used in the description of the specific embodiments or the prior art. Obviously, the drawings in the following description are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without exerting creative efforts.
图1为本发明中提取液不同提取时间下的提取效果(PCR验证)图;Figure 1 is a diagram of the extraction effect (PCR verification) of the extraction solution under different extraction times of the present invention;
图2为不同温度下核酸扩增效果图;Figure 2 shows the effect of nucleic acid amplification at different temperatures;
图3为不同时间下核酸扩增效果图;Figure 3 shows the effect of nucleic acid amplification at different times;
图4为恒温核酸扩增原理示意图;Figure 4 is a schematic diagram of the principle of isothermal nucleic acid amplification;
图5为不同浓度下Cas12a剪切效果图;Figure 5 shows the cleavage effect of Cas12a at different concentrations;
图6为胶体金试纸条检测结果图。Figure 6 shows the test results of colloidal gold test strips.
下面结合具体实施例对本发明进一步进行描述。The present invention will be further described below with reference to specific embodiments.
本发明的基础技术方案如下:The basic technical solution of the present invention is as follows:
一种快速检测宠物病原体核酸检测的试剂,所述的试剂包括提取液、终止液、TSA反应液、Cas12a检测液、胶体金试纸条;A reagent for rapid nucleic acid detection of pet pathogens. The reagent includes an extraction solution, a stop solution, a TSA reaction solution, a Cas12a detection solution, and a colloidal gold test strip;
所述的提取液包括强碱氢氧化物、Tris-HCl;The extraction liquid includes strong alkali hydroxide and Tris-HCl;
所述的终止液包括醋酸、Tris醋酸;The stop solution includes acetic acid and Tris acetic acid;
所述的TSA反应液包括UvsX蛋白、UvsY蛋白、GP32蛋白、Bsu蛋白、dNTP、ATP、Tris缓冲液、磷酸肌酸、肌酸激酶、聚乙二醇35000及MgOAc;The TSA reaction solution includes UvsX protein, UvsY protein, GP32 protein, Bsu protein, dNTP, ATP, Tris buffer, creatine phosphate, creatine kinase, polyethylene glycol 35000 and MgOAc;
所述的Cas12a检测液包括Cas12a蛋白、NaCl、Tris-HCl、MgCl 2、BSA、crRNA及FAM-Bio修饰的ssDNA; The Cas12a detection solution includes Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA;
所述的胶体金试纸条包括T带与C带,其中T带标记有链霉亲和素,C带标记有抗-抗FAM抗体。The colloidal gold test strip includes a T band and a C band, where the T band is labeled with streptavidin and the C band is labeled with anti-anti-FAM antibody.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的提取液中:In the extract:
所述的强碱氢氧化物的质量浓度为25mM~500mM,所述的强碱氢氧化物为NaOH,The mass concentration of the strong alkali hydroxide is 25mM ~ 500mM, and the strong alkali hydroxide is NaOH,
所述的Tris-HCl的质量浓度为10mM~70mM,The mass concentration of Tris-HCl is 10mM ~ 70mM,
所述的EDTA的质量浓度为10mM~50mM;The mass concentration of EDTA is 10mM ~ 50mM;
所述的提取液的pH值为11.4~13.7。The pH value of the extraction liquid is 11.4-13.7.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的终止液中:In the stop solution:
所述的醋酸的质量浓度为1M~5M,The mass concentration of the acetic acid is 1M ~ 5M,
所述的Tris-醋酸的质量浓度为1M;The mass concentration of Tris-acetic acid is 1M;
所述的终止液的pH值为2~2.5。The pH value of the stop solution is 2-2.5.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的TSA反应液中:In the TSA reaction solution:
所述的UvsX蛋白的质量浓度为100-300ng/μL,The mass concentration of the UvsX protein is 100-300ng/μL,
所述的UvsY蛋白的质量浓度为50-100ng/μL,The mass concentration of the UvsY protein is 50-100ng/μL,
所述的GP32蛋白的质量浓度为100-500ng/μL,The mass concentration of the GP32 protein is 100-500ng/μL,
所述的Bsu蛋白的质量浓度为50-200ng/μL,The mass concentration of the Bsu protein is 50-200ng/μL,
所述的dNTP的质量浓度为150-300μM,The mass concentration of the dNTP is 150-300 μM,
所述的ATP的质量浓度为2-10mM,The mass concentration of ATP is 2-10mM,
所述的Tris缓冲液的质量浓度为20-80mM,The mass concentration of the Tris buffer is 20-80mM,
所述的磷酸肌酸的质量浓度为20-80mM,The mass concentration of creatine phosphate is 20-80mM,
所述的肌酸激酶的质量浓度为30-100ng/μL,The mass concentration of creatine kinase is 30-100ng/μL,
所述的聚乙二醇35000的质量浓度为1-7%(w/v),The mass concentration of polyethylene glycol 35000 is 1-7% (w/v),
所述的MgOAc的质量浓度为20mM。The mass concentration of MgOAc is 20mM.
上述所述的快速检测宠物病原体核酸检测的试剂,The above-mentioned reagents for rapid nucleic acid detection of pet pathogens,
所述的Cas12a检测液中:In the Cas12a detection solution:
所述的Cas12a蛋白的质量浓度为1-10uM,The mass concentration of the Cas12a protein is 1-10uM,
所述的NaCl的质量浓度为20-75mM,The mass concentration of NaCl is 20-75mM,
所述的Tris-HCl的质量浓度为5-15mM,The mass concentration of Tris-HCl is 5-15mM,
所述的MgCl 2的质量浓度为1-20mM, The mass concentration of MgCl 2 is 1-20mM,
所述的BSA的质量浓度为50-150ug/ml,The mass concentration of the BSA is 50-150ug/ml,
所述的crRNA的质量浓度为10-50nM,The mass concentration of crRNA is 10-50nM,
所述的FAM-Bio修饰的ssDNA的质量浓度为1-100nM,The mass concentration of the FAM-Bio modified ssDNA is 1-100nM,
所述的Cas12a检测液的pH值为7.9。The pH value of the Cas12a detection solution is 7.9.
一种含有上述所述的试剂的试剂盒。A kit containing the above-mentioned reagents.
一种如上述所述的试剂盒在检测宠物病原体核酸中应用。A kit as described above is used in detecting nucleic acid of pet pathogens.
上述所述的应用,The applications mentioned above,
包括以下步骤:Includes the following steps:
(1)利用所述的提取液提取样本中的核酸,获得样本核酸溶液;(1) Extract the nucleic acid in the sample using the extraction solution to obtain a sample nucleic acid solution;
(2)将所述的终止液全部加入步骤(1)中所获得的样本核酸溶液,以中和样本核酸溶液的pH并得到混合液;其中混合的pH值为6.5-8;(2) Add all the stop solution to the sample nucleic acid solution obtained in step (1) to neutralize the pH of the sample nucleic acid solution and obtain a mixed solution; the mixed pH value is 6.5-8;
(3)利用所述的混合液进行扩增反应并检测样本中的核酸。(3) Use the mixed solution to perform an amplification reaction and detect nucleic acids in the sample.
所述混合液的pH为6.5~8。The pH of the mixed solution is 6.5-8.
需要说明的是,It should be noted,
本发明采用如下核酸提取技术方案:一种强碱性核酸提取方法,包括如下步骤:将样本放入提取液(浓度为25mM~500mM的强碱氢氧化物溶液)中提取核酸;对上述溶液进行的震荡混匀,常温下静置提取,时间为2分钟;加入终止液(浓度为0.1M-1.5M、pH为0.1-1的HCl溶液)并震荡混匀。The present invention adopts the following nucleic acid extraction technical solution: a strong alkaline nucleic acid extraction method, including the following steps: putting the sample into an extraction solution (a strong alkali hydroxide solution with a concentration of 25mM to 500mM) to extract nucleic acids; Shake and mix well, let stand at room temperature for extraction for 2 minutes; add stop solution (HCl solution with a concentration of 0.1M-1.5M and a pH of 0.1-1) and shake to mix.
作为本技术方案的进一步改进,所述强碱氢氧化物为NaOH或KOH;As a further improvement of this technical solution, the strong alkali hydroxide is NaOH or KOH;
作为本技术方案的进一步改进,所述提取液体积为200μl;As a further improvement of this technical solution, the volume of the extraction liquid is 200 μl;
作为本技术方案的进一步改进,所述终止液体积为200μl;As a further improvement of this technical solution, the volume of the stop solution is 200 μl;
作为本技术方案的进一步改进,第三步操作后,核酸可以在-20℃条件下保存一个月;As a further improvement of this technical solution, after the third step, the nucleic acid can be stored at -20°C for one month;
与现有技术相比,本发明通过改变试剂的浓度、pH值、提取的温度和时间等参数,使其能满足现有的各类分子生物学检测、扩增需要,并能在相同时设备和实验条件下同时进行自动化DNA、RNA提取工作。Compared with the existing technology, the present invention can meet the existing needs of various molecular biology detection and amplification by changing the concentration, pH value, extraction temperature and time of reagents and other parameters, and can use the same equipment at the same time. Automatic DNA and RNA extraction work is performed simultaneously under experimental conditions.
同时,本发明采用如下核酸扩增体系方案:包括UvsX蛋白、UvsY蛋白、GP32蛋白和Bsu蛋白:At the same time, the present invention adopts the following nucleic acid amplification system solution: including UvsX protein, UvsY protein, GP32 protein and Bsu protein:
所述UvsX蛋白为如下任意一种:The UvsX protein is any one of the following:
A 1)氨基酸序列如SEQ ID NO:1所示;A 1) The amino acid sequence is shown in SEQ ID NO:1;
A 2)SEQ ID NO:1所示的氨基酸序列的任意一个或几个氨基酸残基经过一个或几个氨基酸残基的取代和/或缺失和/或添加得到的与A1)所示的蛋白具有90%以上的同一性的蛋白;A 2) Any one or several amino acid residues of the amino acid sequence shown in SEQ ID NO:1 has been obtained by substitution and/or deletion and/or addition of one or several amino acid residues and has the same characteristics as the protein shown in A1) Proteins with more than 90% identity;
所述UvsY蛋白为如下任意一种:The UvsY protein is any one of the following:
B 1)氨基酸序列如SEQ ID NO:2所示;B 1) The amino acid sequence is shown in SEQ ID NO:2;
B2)SEQ ID NO:2所示的氨基酸序列的任意一个或几个氨基酸残基经过一个或几个氨基酸残基的取代和/或缺失和/或添加得到的与B1)所示的蛋白具有90%以上的同一性的蛋白;B2) Any one or several amino acid residues of the amino acid sequence shown in SEQ ID NO:2 has been obtained by substituting and/or deleting and/or adding one or several amino acid residues and has 90% similarity with the protein shown in B1) Proteins with more than % identity;
单链结合蛋白GP32为如下任意一种:The single-chain binding protein GP32 is any of the following:
C1)氨基酸序列如SEQ ID NO:3所示;C1) The amino acid sequence is shown in SEQ ID NO:3;
C2)SEQ ID NO:3所示的氨基酸序列的任意一个或几个氨基酸残基经过一个或几个氨基酸残基的取代和/或缺失和/或添加得到的与C1)所示的蛋白具有90%以上的同一性的蛋白;C2) Any one or several amino acid residues of the amino acid sequence shown in SEQ ID NO:3 has been obtained by substituting and/or deleting and/or adding one or several amino acid residues and has 90% similarity with the protein shown in C1) Proteins with more than % identity;
DNA聚合酶Bsu为如下任意一种:DNA polymerase Bsu is any one of the following:
D1)氨基酸序列如SEQ ID NO:4所示;D1) The amino acid sequence is shown in SEQ ID NO:4;
D2)SEQ ID NO:4所示的氨基酸序列的任意一个或几个氨基酸残基经过一个或几个氨基酸残基的取代和/或缺失和/或添加得到的与D1)所示的蛋白具有90%以上的同一性的蛋白;D2) Any one or several amino acid residues of the amino acid sequence shown in SEQ ID NO:4 has been obtained by substituting and/or deleting and/or adding one or several amino acid residues and has 90% similarity with the protein shown in D1) Proteins with more than % identity;
可选的,所述UvsX蛋白、UvsY蛋白、单链结合蛋白GP32、Bsu蛋白的质量比为1:(0.1-4.5):(0.75-2.4):(0.17-0.82);建议优选,所述UvsX蛋白、UvsY蛋白、单链结合蛋白GP32、Bsu蛋白的质量比为260:88:300:90。Optionally, the mass ratio of the UvsX protein, UvsY protein, single-chain binding protein GP32, and Bsu protein is 1: (0.1-4.5): (0.75-2.4): (0.17-0.82); it is recommended that the UvsX be preferred The mass ratio of protein, UvsY protein, single-chain binding protein GP32, and Bsu protein is 260:88:300:90.
可选的,还包括镁离子反应启动剂、dNTP、ATP、Tris-HCl缓冲液、磷酸肌酸、肌酸激酶(CK)、聚乙二醇(PEG35000)中的一种或几种。Optionally, it also includes one or more of magnesium ion reaction initiator, dNTP, ATP, Tris-HCl buffer, creatine phosphate, creatine kinase (CK), and polyethylene glycol (PEG35000).
可选的,所述反应启动剂镁离子,反应体系中启动剂的浓度为20mM。Optionally, the reaction starter is magnesium ion, and the concentration of the starter in the reaction system is 20mM.
可选的,所述反应启动剂镁离子,为MgCl 2或MgOAc。 Optionally, the reaction initiator magnesium ion is MgCl 2 or MgOAc.
反应体系中含有如下各物质:一对正、反引物(每条引物浓度为300-600nM)、100-300ng/μL UvsX蛋白、50-100ng/μL UvsY蛋白、100-500ng/μL GP32蛋白、50-200ng/μL Bsu蛋白、150-300μM dNTP、2-10mM ATP、20-80mM Tris缓冲液、20-80mM磷酸肌酸;3 0-100ng/μL肌酸激酶;1-7%(w/v)聚乙二醇35000,20mM的MgOAc。The reaction system contains the following materials: a pair of forward and reverse primers (concentration of each primer is 300-600nM), 100-300ng/μL UvsX protein, 50-100ng/μL UvsY protein, 100-500ng/μL GP32 protein, 50 -200ng/μL Bsu protein, 150-300μM dNTP, 2-10mM ATP, 20-80mM Tris buffer, 20-80mM creatine phosphate; 3 0-100ng/μL creatine kinase; 1-7% (w/v) Polyethylene glycol 35000, 20mM MgOAc.
一种用于等温核酸检测的试剂盒,试剂盒中包括上述的体系。A kit for isothermal nucleic acid detection, which includes the above system.
一种等温核酸检测方法,将待测样本加入上述放映体系,恒温反应15-30min;于30℃-47℃,恒温反应15-30min;所述方法为非疾病诊断治疗方法。An isothermal nucleic acid detection method, the sample to be tested is added to the above screening system, and the reaction is carried out at a constant temperature for 15-30 minutes; at 30°C-47°C, the reaction is carried out at a constant temperature for 15-30 minutes; the method is a non-disease diagnosis and treatment method.
可选的,待测样本为DNA或RNA。Optionally, the sample to be tested is DNA or RNA.
可选的,待测样本为RNA时,还需在反应体系中加入逆转录酶(MuLV)。Optionally, when the sample to be tested is RNA, reverse transcriptase (MuLV) needs to be added to the reaction system.
第三,本发明采用如下核酸检测方法:包括Cas12a蛋白、NaCl、Tris-HCl、MgCl 2、BSA、crRNA和FAM-Bio修饰的ssDNA。 Third, the present invention adopts the following nucleic acid detection method: including Cas12a protein, NaCl, Tris-HCl, MgCl 2 , BSA, crRNA and FAM-Bio modified ssDNA.
可选的,NaCl浓度为5mM,Tris-HCl浓度为1mM,MgCl2浓度为1mM,BSA浓度为10μg/ml,Cas12a浓度为10μM,crRNA浓度为50nM,ssDNA reporter浓度为15nM。Optional, the NaCl concentration is 5mM, the Tris-HCl concentration is 1mM, the MgCl2 concentration is 1mM, the BSA concentration is 10μg/ml, the Cas12a concentration is 10μM, the crRNA concentration is 50nM, and the ssDNA reporter concentration is 15nM.
可选的,MgCl2可替换成MgOAc。Optionally, MgCl2 can be replaced with MgOAc.
可选的,ssDNA reporter浓度可替换为10mM。Optionally, the ssDNA reporter concentration can be replaced with 10mM.
可选的,ssDNA reporter浓度可替换为5mM。Optionally, the ssDNA reporter concentration can be replaced with 5mM.
需要注意的是,以下实施例中,未提及具体的浓度的试剂,均以其中间值作为最优选值进行实验。同时,关于引物I,Primer F:5’-GTAGTTGTAAATAATATGGATAAAACTGCAG-3’,Primer R:5’-GGCTGAGTAGCAGATTCTGAAACAGTCTTT-3’,分别如SEQ ID NO:5与SEQ ID NO:6所示。It should be noted that in the following examples, specific concentrations of reagents are not mentioned, and experiments are conducted with the intermediate values as the most preferred values. At the same time, regarding primer I, Primer F: 5'-GTAGTTGTAAATAATATGGATAAAACTGCAG-3', Primer R: 5'-GGCTGAGTAGCAGATTCTGAAACAGTCTTT-3', as shown in SEQ ID NO: 5 and SEQ ID NO: 6 respectively.
实施例1Example 1
猫细小病毒的提取步骤如下:The steps for extracting feline parvovirus are as follows:
(1)将采集的样本放入提取液(浓度为25mM~500mM的强碱氢氧化物溶液,建议选择100mM)中提取核酸;对上述溶液进行的震荡混匀,常温下静置提取,时间为2分钟;加入终止液(浓度为0.1M-1.5M、pH为0.1-1的HCl溶液,建议选择浓度为0.8M、pH为0.5)并震荡混匀。(1) Put the collected samples into the extraction solution (a strong alkali hydroxide solution with a concentration of 25mM to 500mM, it is recommended to choose 100mM) to extract nucleic acids; shake and mix the above solution, and let it stand at room temperature for extraction. 2 minutes; add stop solution (HCl solution with a concentration of 0.1M-1.5M and a pH of 0.1-1, it is recommended to choose a concentration of 0.8M and a pH of 0.5) and shake to mix.
(2)进行以下几组反应:(2) Carry out the following sets of reactions:
a-中加入空白拭子;Add a blank swab to a-;
b-中加入猫细小样本拭子20s;b-Add cat fine sample swab for 20s;
c-中加入猫细小样本拭子40s;c-Add cat fine sample swab for 40s;
d-中加入猫细小样本拭子60s;Add cat fine sample swab to d- for 60 seconds;
e-中加入猫细小样本拭子90s;Add cat fine sample swab to e- for 90s;
f-中加入猫细小样本拭子120s。Add cat fine sample swab to f- for 120s.
(3)对上述液体分别使用特异性引物I和PCR预混液,在Applied Biosystems 2720 P CR仪进行PCR扩增,程序设置如下:预变性(94℃,5min)-变性(94℃,30s)-退火(55℃,30s)-延伸(72℃,20s)go to变性,28cycle-终延伸(72℃,10min)。(3) Use specific primer I and PCR master mix for the above liquids, and perform PCR amplification on the Applied Biosystems 2720 P CR instrument. The program settings are as follows: predenaturation (94°C, 5min) - denaturation (94°C, 30s) - Annealing (55℃, 30s)-extension (72℃, 20s) go to denaturation, 28cycle-final extension (72℃, 10min).
(4)结果(4)Results
实时结果如图1所示,结果表明,在相同条件下,同时考虑效果和效率,在2min时提取效果最好,效率最高。The real-time results are shown in Figure 1. The results show that under the same conditions, taking both effect and efficiency into consideration, the extraction effect is best and the efficiency is highest at 2 minutes.
实施例2Example 2
对上述提取液e进行扩增温度测试:Conduct amplification temperature test on the above extraction liquid e:
(1)配置反应体系(50μL体系):5μL模板DNA e、引物Ⅰ(每条引物420nM)、1μlMuLV逆转录酶、260ng/μL UvsX蛋白、88ng/μL UvsY蛋白、300ng/μL GP32蛋白、90ng/μL Bsu蛋白、240μM dNTP、5mM ATP、100mM醋酸钾、100mM Tris缓冲液、40mM磷酸肌酸;90ng/μL肌酸激酶;6%聚乙二醇35000。(1) Configure the reaction system (50μL system): 5μL template DNA e, primer I (420nM each primer), 1μl MuLV reverse transcriptase, 260ng/μL UvsX protein, 88ng/μL UvsY protein, 300ng/μL GP32 protein, 90ng/ μL Bsu protein, 240 μM dNTP, 5mM ATP, 100mM potassium acetate, 100mM Tris buffer, 40mM creatine phosphate; 90ng/μL creatine kinase; 6% polyethylene glycol 35000.
(2)进行以下几组反应:(2) Carry out the following sets of reactions:
g-以DEPC水代替模板DNA e;g-Replace template DNA with DEPC water e;
h-中加入终浓度为20mM的MgOAc启动,反应温度10℃,反应30min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to h-, the reaction temperature is 10°C, and the reaction is terminated by purifying the product after 30 minutes of reaction;
i-1中加入终浓度为20mM的MgOAc启动,反应温度20℃,反应30min后对产物提纯终止反应;MgOAc with a final concentration of 20mM was added to i-1 to start, the reaction temperature was 20°C, and the reaction was terminated by purifying the product after 30 minutes of reaction;
j-1中加入终浓度为20mM的MgOAc启动,反应温度30℃,反应30min后对产物提纯终止反应;MgOAc with a final concentration of 20mM was added to j-1 to start, the reaction temperature was 30°C, and the reaction was terminated by purifying the product after 30 minutes of reaction;
k-中加入终浓度为20mM的MgOAc启动,反应温度35℃,反应30min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to k-, the reaction temperature is 35°C, and the reaction is terminated by purifying the product after 30 minutes of reaction;
m-中加入终浓度为20mM的MgOAc启动,反应温度40℃,反应30min后对产物提纯终止反应;MgOAc with a final concentration of 20mM was added to m- to start, the reaction temperature was 40°C, and the reaction was terminated by purifying the product after 30 minutes of reaction;
n-中加入终浓度为20mM的MgOAc启动,反应温度47℃,反应30min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to n-, the reaction temperature is 47°C, and the reaction is terminated by purifying the product after 30 minutes of reaction;
(3)结果(3)Results
实时结果如图2所示,结果表明,反应在20-47℃均可以达到扩增效果。The real-time results are shown in Figure 2. The results show that the reaction can achieve amplification effects at 20-47°C.
实施例3Example 3
对上述提取液e进行扩增时间测试Perform amplification time test on the above extract e
(1)配置反应体系(50μL体系):5μL模板DNA e、引物Ⅰ(每条引物420nM)、1μlMuLV逆转录酶、260ng/μL UvsX蛋白、88ng/μL UvsY蛋白、300ng/μL GP32蛋白、90ng/ μL Bsu蛋白、240μM dNTP、5mM ATP、100mM醋酸钾、100mM Tris缓冲液、40mM磷酸肌酸;90ng/μL肌酸激酶;6%聚乙二醇35000。(1) Configure the reaction system (50μL system): 5μL template DNA e, primer I (420nM each primer), 1μl MuLV reverse transcriptase, 260ng/μL UvsX protein, 88ng/μL UvsY protein, 300ng/μL GP32 protein, 90ng/ μL Bsu protein, 240 μM dNTP, 5mM ATP, 100mM potassium acetate, 100mM Tris buffer, 40mM creatine phosphate; 90ng/μL creatine kinase; 6% polyethylene glycol 35000.
(2)进行以下几组反应:(2) Carry out the following sets of reactions:
o-以DEPC水代替模板DNA e;o-Replace template DNA e with DEPC water;
p-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应5min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to p-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 5 minutes of reaction;
q-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应10min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to q-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 10 minutes of reaction;
r-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应15min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to r-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 15 minutes of reaction;
s-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应20min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to s-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 20 minutes of reaction;
t-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应25min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to t-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 25 minutes of reaction;
u-中加入终浓度为20mM的MgOAc启动,反应温度37℃,反应30min后对产物提纯终止反应;Start by adding MgOAc with a final concentration of 20mM to u-, the reaction temperature is 37°C, and the reaction is terminated by purifying the product after 30 minutes of reaction;
(3)结果(3)Results
实时结果如图3所示,结果表明,扩增效果在前30min随时间增加效果变强,在30min达到最大量。The real-time results are shown in Figure 3. The results show that the amplification effect becomes stronger with time in the first 30 minutes and reaches the maximum amount at 30 minutes.
实施例4Example 4
对上述提取液u进行Cas12a浓度测试。Carry out Cas12a concentration test on the above extract u.
(1)配置反应体系(20μl体系):NaCl 5mM,Tris-HCl 1mM,MgCl 2 1mM,BSA 10μg/ml,crRNA 50nM,ssDNA reporter 15nM(F-Q修饰),Target(u)2μl。 (1) Configure the reaction system (20μl system): NaCl 5mM, Tris-HCl 1mM, MgCl 2 1mM, BSA 10μg/ml, crRNA 50nM, ssDNA reporter 15nM (FQ modification), Target (u) 2μl.
(2)进行以下几组反应:(2) Carry out the following sets of reactions:
v-中不加入Cas12a;Cas12a is not added to v-;
w-中加入Cas12a终浓度1μM;Cas12a was added to w- at a final concentration of 1 μM;
x-中加入Cas12a终浓度5μM;Add Cas12a to x- at a final concentration of 5 μM;
y-中加入Cas12a终浓度10μM;Add Cas12a to y- at a final concentration of 10 μM;
z-中加入Cas12a终浓度20μM;Add Cas12a to z- at a final concentration of 20 μM;
(3)结果使用ABI StepOne Plus qPCR仪读取荧光数据。(3) The results were read using the ABI StepOne Plus qPCR instrument to read the fluorescence data.
实时结果如图5所示,结果表明,在本发明所述体系中Cas12a终浓度为终浓度10μM 时剪切效率最高。The real-time results are shown in Figure 5. The results show that in the system of the present invention, the shearing efficiency is highest when the final concentration of Cas12a is 10 μM.
实施例5Example 5
对上述提取液u进行Cas12a剪切并使用试纸条读取结果。Perform Cas12a cleavage on the above extract u and read the result using a test strip.
(1)配置反应体系(20μl体系):NaCl 5mM,Tris-HCl 1mM,MgCl 2 1mM,BSA 10μg/ml,crRNA 50nM,ssDNA reporter 15nM(F-Bio修饰)。 (1) Configure the reaction system (20μl system): NaCl 5mM, Tris-HCl 1mM, MgCl 2 1mM, BSA 10μg/ml, crRNA 50nM, ssDNA reporter 15nM (F-Bio modified).
(2)进行以下几组反应:(2) Carry out the following sets of reactions:
pc-中加入Target(u)2μl;Add Target(u)2μl to pc-;
nc-中加入DEPC 2μl;Add DEPC 2μl to nc-;
(3)37℃条件下孵育20min;(3) Incubate at 37°C for 20 minutes;
(4)分别插入胶体金试纸条;(4) Insert the colloidal gold test strips respectively;
(5)结果(5)Results
结果如图6所示,结果表明,C带有条带T带无条带为阳性(pc);C带有条带T带有条带为阴性。The results are shown in Figure 6. The results show that C has a band and T has no band, which is positive (pc); C has a band and T has a band, which is negative.
以上内容是结合具体实施方式对本发明作进一步详细说明,不能认定本发明具体实施只局限于这些说明,对于本发明所属技术领域的普通技术人员来说,在不脱离本发明的构思的前提下,还可以做出若干简单的推演或替换,都应当视为属于本发明所提交的权利要求书确定的保护范围。The above content is a further detailed description of the present invention in combination with specific implementation modes. It cannot be concluded that the specific implementation of the present invention is limited to these descriptions. For those of ordinary skill in the technical field to which the present invention belongs, without departing from the concept of the present invention, Several simple deductions or substitutions can also be made, which should be deemed to fall within the protection scope determined by the claims submitted for the present invention.
Claims (8)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211075760.XA CN116064945A (en) | 2022-09-05 | 2022-09-05 | Reagent and kit for rapidly detecting pet pathogen nucleic acid detection and application of reagent and kit |
| CN202211075760.X | 2022-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024050998A1 true WO2024050998A1 (en) | 2024-03-14 |
Family
ID=86172214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2022/135025 Ceased WO2024050998A1 (en) | 2022-09-05 | 2022-11-29 | Nucleic acid detection reagent for rapidly detecting pathogen of pets, and kit and use thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN116064945A (en) |
| WO (1) | WO2024050998A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118147372A (en) * | 2024-05-09 | 2024-06-07 | 北京凡知医学科技有限公司 | Nucleic acid detection test paper box and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102321767A (en) * | 2011-10-18 | 2012-01-18 | 湖南省作物研究所 | Simple sequence repeat-polymerase chain reaction (SSR-PCR)-based hybrid rape seed purity detection method |
| CN102719427A (en) * | 2012-07-14 | 2012-10-10 | 李爱强 | Method for extracting DNA (deoxyribonucleic acid) by alkaline cracking |
| CN109055611A (en) * | 2018-08-24 | 2018-12-21 | 深圳市芯思微生物科技有限公司 | For detecting the kit of HPV |
| CN109652508A (en) * | 2018-12-04 | 2019-04-19 | 浙江天杭生物科技股份有限公司 | A kind of easy quickly detection nuclei aoid methods |
| WO2020199342A1 (en) * | 2019-04-02 | 2020-10-08 | 苏州先达基因科技有限公司 | Room temperature nucleic acid amplification reaction |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017034019A1 (en) * | 2015-08-26 | 2017-03-02 | 株式会社カネカ | Nucleic acid detection device and nucleic acid detection method |
| CN106967843B (en) * | 2017-04-06 | 2020-07-14 | 苏州点晶生物科技有限公司 | Rapid detection kit for canine parvovirus nucleic acid |
| US20230159986A1 (en) * | 2020-04-22 | 2023-05-25 | The Regents Of The University Of California | Methods for detecting and sequencing a target nucleic acid |
| CN114480744B (en) * | 2022-03-11 | 2022-11-11 | 深圳市研元生物科技有限公司 | New coronavirus isothermal detection kit based on CRISPR-Cas system, use method and application |
-
2022
- 2022-09-05 CN CN202211075760.XA patent/CN116064945A/en active Pending
- 2022-11-29 WO PCT/CN2022/135025 patent/WO2024050998A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102321767A (en) * | 2011-10-18 | 2012-01-18 | 湖南省作物研究所 | Simple sequence repeat-polymerase chain reaction (SSR-PCR)-based hybrid rape seed purity detection method |
| CN102719427A (en) * | 2012-07-14 | 2012-10-10 | 李爱强 | Method for extracting DNA (deoxyribonucleic acid) by alkaline cracking |
| CN109055611A (en) * | 2018-08-24 | 2018-12-21 | 深圳市芯思微生物科技有限公司 | For detecting the kit of HPV |
| CN109652508A (en) * | 2018-12-04 | 2019-04-19 | 浙江天杭生物科技股份有限公司 | A kind of easy quickly detection nuclei aoid methods |
| WO2020199342A1 (en) * | 2019-04-02 | 2020-10-08 | 苏州先达基因科技有限公司 | Room temperature nucleic acid amplification reaction |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118147372A (en) * | 2024-05-09 | 2024-06-07 | 北京凡知医学科技有限公司 | Nucleic acid detection test paper box and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116064945A (en) | 2023-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3636769B1 (en) | Sample nucleic acid measurement test kit, reagent, and application thereof | |
| US9222126B2 (en) | Methods for point-of-care detection of nucleic acid in a sample | |
| JP6821531B2 (en) | A method for determining the amount of nucleic acid of interest in an unprocessed sample | |
| CN111808991A (en) | A kind of gene detection method and system based on RT-RPA system and CRISPR/Cas system and its application | |
| CN104975013A (en) | Method for accelerating spiral reaction of polymerase and application of method | |
| CN104195268A (en) | Reagent box for detecting aftosa A type, O type and Asia 1 type viruses and preparing method thereof | |
| CN103540687B (en) | LAMP detection primer group and kit for white spot syndrome virus (WSSV) | |
| CN114410836A (en) | A kit and method for detecting human parvovirus B19 integrating sample processing, nucleic acid extraction and multiple isothermal amplification | |
| Kramná et al. | Virome sequencing of stool samples | |
| JP6637100B2 (en) | Method for isolating nucleic acid from specimen in liquid-based cytological preservative containing formaldehyde | |
| CN103998625B (en) | Method and system for virus detection | |
| CN107955840A (en) | For detecting double PCR primer, detection method and the kit of swine foot-and-mouth disease virus and Sai Neijia paddy virus | |
| CN118109650A (en) | Visual detection kit for detecting A-type sai virus nucleic acid based on RPA-CRISPR/Cas12a | |
| WO2024050998A1 (en) | Nucleic acid detection reagent for rapidly detecting pathogen of pets, and kit and use thereof | |
| WO2021188935A1 (en) | Materials and methods for detecting coronavirus | |
| WO2021216573A1 (en) | Scalable, easy-to-deploy system and reagents thereof for crispr-associated nuclease-based detection of pathogen genetic material | |
| CN118497418A (en) | A canine and feline parvovirus kit and detection method based on RAA and CRISPR technology | |
| US20220195541A1 (en) | Detecting a target nucleic acid in a biological sample | |
| US11913062B2 (en) | System and method for isolation and qualification of nucleic acids | |
| Selvam et al. | RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods. Diagnostics 2021, 11, 1646 | |
| Zeinoddini et al. | A Review of the New Diagnostic Kits Design based on CRISPR | |
| Zeinoddini et al. | Journal of Police Medicine | |
| CN121109659A (en) | A Multiplex TMA-CRISPR Kit for Respiratory Pathogen RNA and Its Application | |
| Shahi et al. | Overview of the different methods for RNA preparation in COVID-19 diagnosis process during the pandemic | |
| Morel et al. | Comparative study of a novel application of automated HR HPV assay and stability in a previously untested Preservative media |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22957957 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 18/07/2025) |